Brief: ELEVAI Labs Subsidiary, Elevai Skincare Announces Positive Results For E-Series Exosome Technology In Potential Melasma Applications
10/09/2024 13:24
Sept 10 (Reuters) - Elevai Labs Inc ELAB.O :
* ELEVAI LABS INC SUBSIDIARY, ELEVAI SKINCARE INC ANNOUNCES
POSITIVE RESULTS FOR E-SERIES EXOSOME TECHNOLOGY IN POTENTIAL
MELASMA APPLICATIONS
* ELEVAI LABS-EARLY RESULTS SHOW SYNERGISTIC EFFECTS OF
ELEVAI
EXOSOMES, LASER TREATMENTS FOR MELASMA IMPROVEMENT WITH NO
RECURRENCE AFTER 6 MONTHS
Source text for Eikon: ID:nGNX6NcdKW
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Holdings Signs Non-Binding Letter Of Intent To Acquire Majority Stake In US-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, And Semiconductor Markets
Brief: PMGC Holdings Offers $7.8 Million In Common Stock To Streeterville Capital
NASDAQ RESUMED AT 12:33 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:28 PM
NASDAQ RESUMED AT 09:46 AM